Significant Ownership of FARALLON CAPITAL MANAGEMENT, L.L.C.

Large-stake snapshot 1 signal
Large-stake filing summary
  • Recent SEC Schedule 13D/G filings for FARALLON CAPITAL MANAGEMENT, L.L.C. focus on large-stake beneficial ownership disclosures and amendments.
  • Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
Manager Names, identifiers, and filing context for this profile. 2 identity fields
Manager signature
/s/ Hannah E. Dunn - Managing Member
Manager location
San Francisco, CA

Follow Filing Activity

Follow FARALLON CAPITAL MANAGEMENT, L.L.C. with Pro and return when a new Schedule 13D/G filing changes the record on this page.

Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.

Review Pro alert access Already have an account? Sign in and return here

Significant Ownership of FARALLON CAPITAL MANAGEMENT, L.L.C.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
PTGX Protagonist Therapeutics, Inc. Common Stock, par value $0.00001 per share (the "Shares") 10% $835,597,827 6,433,119 Farallon Capital Management, L.L.C. 30 Jun 2026
BEAM Beam Therapeutics Inc. Common Stock, par value $0.01 per share (the "Shares") 10% $368,308,762 10,282,210 Farallon Capital Management, L.L.C. 30 Jun 2026
AGIO AGIOS PHARMACEUTICALS, INC. Common Stock, par value $0.001 per share (the "Shares") 9.9% $239,950,570 5,917,400 Farallon Capital Management, L.L.C. 30 Jun 2026
TNGX Tango Therapeutics, Inc. Common stock, par value $0.001 per share (the "Shares") 9.8% $498,518,530 16,270,187 Farallon Capital Management, L.L.C. 30 Jun 2026
NERV Minerva Neurosciences, Inc. Common Stock, $0.0001 par value per share (the "Shares") 9.7% $23,271,600 4,730,000 Farallon Capital Management, L.L.C. 30 Jun 2026
GRAL GRAIL, Inc. Common Stock, par value $0.001 per share (the "Shares") 9.6% $284,111,340 4,161,584 Farallon Capital Management, L.L.C. 30 Jun 2026
LQDA Liquidia Corporation Common Stock, par value $0.001 per share (the "Shares") 9.4% $662,594,660 8,365,038 Farallon Capital Management, L.L.C. 30 Jun 2026
CATX Lantheus Holdings, Inc. Common Stock, par value $0.01 per share (the "Shares") 8.6% 5,583,479 Farallon Capital Management, L.L.C. 30 Jun 2026
CRNX Crinetics Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (the "Shares") 8.5% $752,117,830 8,989,098 Farallon Capital Management, L.L.C. 30 Jun 2026
ENTA ENANTA PHARMACEUTICALS INC Common Stock, par value $0.01 per share (the "Shares") 8.3% $35,088,111 2,418,202 Farallon Capital Management, L.L.C. 30 Jun 2026
ASMB Assembly Biosciences, Inc. Common Stock, par value $0.001 per shares (the "Shares") 8.1% $46,484,972 1,604,590 Farallon Capital Management, L.L.C. 30 Jun 2026
SVRA Savara Inc. Common Stock, par value $0.001 per share (the "Shares") 6.8% $94,350,000 15,000,000 Farallon Capital Management, L.L.C. 30 Jun 2026
RVMD Revolution Medicines, Inc. Common Stock, par value $0.0001 per share (the "Shares") 6.4% $2,566,879,557 13,564,149 Farallon Capital Management, L.L.C. 30 Jun 2026
EXEL EXELIXIS, INC. Common Stock, par value $0.001 per share (the "Shares") 5.6% $790,379,065 13,989,010 Farallon Capital Management, L.L.C. 14 Aug 2026
BBIO BridgeBio Pharma, Inc. Common Stock, par value $0.001 per share (the "Shares") 5.5% $836,992,038 10,743,063 Farallon Capital Management, L.L.C. 30 Jun 2026
IFRX InflaRx N.V. Ordinary Shares, nominal value 0.12 EUR per share (the "Shares") 2.3% $7,182,000 3,325,000 Farallon Capital Management, L.L.C. 30 Jun 2026
BBNX Beta Bionics, Inc. Common Stock, $0.0001 par value per share (the "Shares") 1.3% $9,948,400 595,000 Farallon Capital Management, L.L.C. 30 Jun 2026
TYRA Tyra Biosciences, Inc. Common Stock, $0.0001 par value per share (the "Shares") 0% $195,420 6,000 Farallon Capital Management, L.L.C. 30 Jun 2026
CNTA Centessa Pharmaceuticals plc Ordinary Shares, nominal value GBP 0.002 per share (the "Ordinary Shares") 0% $0 -$372,461,197 0 -100% FARALLON CAPITAL MANAGEMENT, L.L.C. 24 Jun 2026
A105PS Marblegate Acquisition Corp. Class A Common Stock, par value $0.0001 per share (the "Shares") 0% $0 0 Grassland Investors, LLC 30 Jun 2025

Schedules 13D/G Reported by FARALLON CAPITAL MANAGEMENT, L.L.C.:

Sym Target Class Ownership Change Current shares Change Value Reporting name Form Report period Filing date
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .